Physician

Infectious Disease

Dr. Alexander J. Lepak, MD

Alexander Lepak works in the field of Infectious Disease. He went to medical school at University of Wisconsin School of Medicine and Public Health. Alexander J. Lepak is a published doctor. He published 16 publications, including: 'Extended Interval Micafungin Using Humanized PK/PD in Mice.' Alexander Lepak accepts Medicare.

Publications

Extended Interval Micafungin Using Humanized PK/PD in Mice.
In vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709 and its Active Metabolite TXA-707, in the Murine Neutropenic Thigh Infection Model.
In vivo Pharmacokinetics and Pharmacodynamics of the Lantibiotic, NAI-107, in the Neutropenic Murine Thigh Infection Model.
Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), using an In Vivo Murine Invasive Candidiasis Model.
Antifungal Pharmacokinetics and Pharmacodynamics.
Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the Ceftolozane In Vivo Pharmacokinetic/Pharmacodynamic Target.
Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates...
Isavuconazole Pharmacodynamic Target Determination for Candida species in an In vivo Murine Disseminated Candidiasis Model.
Impact of in vivo Triazole and Echinocandin Combination Therapy for Invasive Pulmonary Aspergillosis: Enhanced Efficacy against Cyp51 Mutant Isolates.
Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization.
Posaconazole Pharmacodynamic Target Determination against Wild-type and Cyp51 Mutant Isolates of Aspergillus fumigatus in an in vivo Model of Invasive Pulmonary Asperg...
Comparative pharmacodynamics of the new oxazolidinone tedizolid phosphate and linezolid in a neutropenic murine Staphylococcus aureus pneumonia model.
Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In vivo Pharmacodynamic Evaluation Against C. glabrata with and without Fks Mutations.
Antifungal PK/PD Considerations in Fungal Pulmonary Infections.
Time course global gene expression analysis of an in vivo Candida biofilm.

Schools

University of Wisconsin Madison

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

University of Wisconsin
University of Wisconsin School of Medicine and Public Health

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1265490536
Last Name Of The Provider	LEPAK
First Name Of The Provider	ALEXANDER
View All

Similar Doctors

	Dr. William A. Craig, MD
	Dr. Barry C. Fox, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Meghan B. Brennan, MD This Doctor is OpenDoctor Recommended.
	Dr. Gregory M. Gauthier, MD
	Dr. Julie E. Horbul, MD This Doctor is OpenDoctor Recommended.
	Dr. Nasia Safdar, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ryan P. Westergaard, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher J. Crnich, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Anna B. Corey, MD This Doctor is OpenDoctor Recommended.
	Dr. David R. Andes, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Robert T. Striker, MD This Doctor is OpenDoctor Recommended.